At Tenomix, our mission is to develop novel technologies that target inefficiencies in the pathology workflow, to optimize cancer care and reduce healthcare costs.

Our dedicated team of engineers, medical doctors, and clinical scientists is currently working on Tenomix’s flagship device, which autonomously searches for lymph nodes in resected cancer tissues and marks their locations for efficient extraction.

This bench-top device replaces the existing tedious and unreliable manual lymph node finding process and greatly improves the speed and reliability of the cancer staging process. This enables clinicians to make better-informed treatment decisions, resulting in fewer patient complications and fatalities and ensures hospitals continuously meet their quality metrics.